Product Description
Menotas HP 150 IU Injection is a sought-after hormonal preparation, formulated with first-rate Menotropins (150 IU FSH & LH), ideal for female infertility management and assisted reproductive technology (ART) treatments. This rare, high-value medication is available for a limited time and must be prescribed and administered under a qualified healthcare professional's supervision. Each white to off-white lyophilized vial, marketed by Emcure Pharmaceuticals Ltd., is supplied with solvent for reconstitution. Proper refrigeration (2C-8C) maintains its 24-month shelf life. Indicated for ovulation induction only in adult women.
Outstanding Features and Versatile Usage
Menotas HP 150 IU Injection offers valorous value with its high-purity menotropin formulation, making it a special choice for ART and ovulation induction. The product's extra features include suitability for both intramuscular and subcutaneous administration, and a shelf life of 24 months under recommended refrigeration. Its usage type is strictly prescription-based and intended for adult women under medical supervision. Each pack includes a vial with solvent, ensuring convenient and accurate reconstitution prior to administration.
Sample Policy, Certification, and Delivery Details
A sample of Menotas HP 150 IU Injection is typically available upon request, subject to dealer and distributor policies. Emcure Pharmaceuticals upholds first-rate quality certifications that meet Indian regulatory standards, ensuring product reliability. Delivery timelines vary according to freight and location, with standard charges applicable. The injection is securely packaged and shipped under cold chain requirements, ensuring the shipment remains within the recommended temperature during transit for optimal efficacy and safety.
FAQ's of Menotas Hp 150 Iu Injection:
Q: How should Menotas HP 150 IU Injection be administered?
A: Menotas HP 150 IU Injection should be administered either intramuscularly or subcutaneously, strictly under the supervision of a qualified healthcare professional, following your physician's dosage instructions.
Q: What is the primary benefit of Menotas HP 150 IU Injection?
A: The primary benefit of Menotas HP 150 IU Injection is its effectiveness in inducing ovulation in women undergoing infertility treatment, particularly in assisted reproductive technology procedures.
Q: When is reconstitution of the injection required?
A: Reconstitution is required immediately prior to use, using the solvent provided with the pack, as instructed by the healthcare professional.
Q: Where should Menotas HP 150 IU Injection be stored?
A: The injection should be stored in a refrigerator at temperatures between 2C and 8C. It should never be frozen.
Q: What is the process for obtaining Menotas HP 150 IU Injection?
A: This is a prescription-only medication. Contact a healthcare provider for an evaluation and appropriate prescription, then purchase from a certified pharmacy or distributor.
Q: Are there any side effects or warnings associated with its use?
A: Possible side effects include headache, abdominal pain, nausea, or injection site reactions. It should not be used during pregnancy or lactation unless expressly recommended by a physician.